BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31883337)

  • 1. Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
    Kevans D; Kirsch R; Dargavel C; Kabakchiev B; Riddell R; Silverberg MS
    Inflamm Bowel Dis; 2020 Oct; 26(11):1722-1729. PubMed ID: 31883337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
    Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
    J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.
    Bessissow T; Lemmens B; Ferrante M; Bisschops R; Van Steen K; Geboes K; Van Assche G; Vermeire S; Rutgeerts P; De Hertogh G
    Am J Gastroenterol; 2012 Nov; 107(11):1684-92. PubMed ID: 23147523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
    Calafat M; Lobatón T; Hernández-Gallego A; Mañosa M; Torres P; Cañete F; Cabré E; Ojanguren I; Domènech E
    Dig Liver Dis; 2017 Dec; 49(12):1327-1331. PubMed ID: 28958412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE).
    Osterman MT; Scott FI; Fogt FF; Gilroy ED; Parrott S; Galanko J; Cross R; Moss A; Herfarth HH; Higgins PDR
    Inflamm Bowel Dis; 2021 Jan; 27(2):207-214. PubMed ID: 32170946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa.
    Ozaki R; Kobayashi T; Okabayashi S; Nakano M; Morinaga S; Hara A; Ohbu M; Matsuoka K; Toyonaga T; Saito E; Hisamatsu T; Hibi T
    J Crohns Colitis; 2018 Nov; 12(11):1288-1294. PubMed ID: 29939231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
    Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
    Cushing KC; Tan W; Alpers DH; Deshpande V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2020 Feb; 51(3):347-355. PubMed ID: 31696961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
    Bessissow T; Kron CM; Marcus V; Lemieux C; Laneuville J; Afif W; Wild G; Lakatos PL; Brassard P; Bitton A
    Am J Gastroenterol; 2022 Oct; 117(10):1632-1638. PubMed ID: 35862833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Simplified Geboes Score for Ulcerative Colitis.
    Jauregui-Amezaga A; Geerits A; Das Y; Lemmens B; Sagaert X; Bessissow T; Lobatón T; Ferrante M; Van Assche G; Bisschops R; Geboes K; De Hertogh G; Vermeire S
    J Crohns Colitis; 2017 Mar; 11(3):305-313. PubMed ID: 27571771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.
    Rosenberg L; Nanda KS; Zenlea T; Gifford A; Lawlor GO; Falchuk KR; Wolf JL; Cheifetz AS; Goldsmith JD; Moss AC
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):991-6. PubMed ID: 23591275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?
    Mohammed N; Subramanian V
    World J Gastroenterol; 2016 Nov; 22(42):9324-9332. PubMed ID: 27895420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.
    Lobatón T; Bessissow T; De Hertogh G; Lemmens B; Maedler C; Van Assche G; Vermeire S; Bisschops R; Rutgeerts P; Bitton A; Afif W; Marcus V; Ferrante M
    J Crohns Colitis; 2015 Oct; 9(10):846-52. PubMed ID: 26116558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
    J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.